Perceptive Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-172,991
| Closed | -$25.2M | – | 116 |
|
|
2022
Q2 | $25.2M | Sell |
172,991
-7,088
| -4% | -$1.03M | 0.79% | 30 |
|
|
2022
Q1 | $29.4M | Buy |
+180,079
| New | +$29.4M | 0.59% | 42 |
|
|
2019
Q1 | – | Sell |
-262,241
| Closed | -$18.5M | – | 99 |
|
|
2018
Q4 | $18.5M | Sell |
262,241
-935,753
| -78% | -$65.9M | 0.7% | 37 |
|
|
2018
Q3 | $105M | Sell |
1,197,994
-648,917
| -35% | -$56.8M | 2.8% | 6 |
|
|
2018
Q2 | $182M | Buy |
1,846,911
+566,109
| +44% | +$55.8M | 4.77% | 4 |
|
|
2018
Q1 | $153M | Sell |
1,280,802
-50,000
| -4% | -$5.95M | 4.27% | 5 |
|
|
2017
Q4 | $169M | Sell |
1,330,802
-458,000
| -26% | -$58.2M | 5.6% | 4 |
|
|
2017
Q3 | $210M | Sell |
1,788,802
-43,959
| -2% | -$5.16M | 8.03% | 3 |
|
|
2017
Q2 | $146M | Buy |
1,832,761
+729,286
| +66% | +$58.2M | 7.36% | 3 |
|
|
2017
Q1 | $56.6M | Buy |
1,103,475
+985,000
| +831% | +$50.5M | 3.22% | 6 |
|
|
2016
Q4 | $4.44M | Buy |
+118,475
| New | +$4.44M | 0.32% | 61 |
|
|
2014
Q2 | – | Sell |
-50,000
| Closed | -$3.36M | – | 113 |
|
|
2014
Q1 | $3.36M | Buy |
+50,000
| New | +$3.36M | 0.35% | 50 |
|